Skip to content

Comparative Analysis of Serum and Urine Metabolomics: The Impact of Remimazolam Tosilate Application During General Anesthesia on Postoperative Delirium

Comparative Analysis of Serum and Urine Metabolomics: The Impact of Remimazolam Tosilate Application During General Anesthesia on Postoperative Delirium

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105967
Enrollment
Unknown
Registered
2025-07-15
Start date
2025-07-15
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium

Interventions

Experimental group:The induction dose of remimazolam tosilate was age-stratified: 0.25 mg/kg for patients aged 65-74 years and 0.2 mg/kg for those >75 years. The maintenance dose was 0.3-0.5 mg/kg/h.
Control group:Propofol was administered at 0.15 mg/kg for induction and maintained at 2-4 mg/kg/h.

Sponsors

The Affiliated Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective surgery, aged >= 65 years; 2. Participating in medium to large-scale general anesthesia surgeries (gastrointestinal, hepatobiliary, orthopedic), with an estimated surgical duration of >= 2 hours; 3. ASA grade I–III.

Exclusion criteria

Exclusion criteria: 1.Inability to complete the neurocognitive assessment due to language, visual, or auditory impairments; 2. Obvious dementia (Mini-Mental State Examination [MMSE] score <24); 3. History of cerebrovascular disease, intracranial disease, or psychiatric illness, or regular use of benzodiazepines; 4. Undergoing cardiac or cranial surgery; 5. Expected postoperative hospital stay of less than 5 days; 6. Unwillingness to participate in postoperative assessments and sampling; 7. Preoperative MMSE score below the normal range; 8. Presence of delirium before surgery.

Design outcomes

Primary

MeasureTime frame
Incidence of delirium within 3 days after surgery;The incidence of postoperative delirium requiring pharmacological treatment;

Secondary

MeasureTime frame
Time from the end of surgery to extubation;

Countries

China

Contacts

Public ContactZhong Yi

The Affiliated Hospital of Guizhou Medical University

490173559@qq.com+86 133 1221 5880

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026